Krabbe's Disease

This PatientPlus article is written for healthcare professionals so the language may be more technical than the condition leaflets. You may find the abbreviations list helpful.

Synonyms: globoid cell leukodystrophy, globoid cell leukoencephalopathy, galactosylceramide lipidosis, galactosylceramidase (GALC) deficiency

This is an autosomal recessive leukodystrophy. There is a lack of the enzyme galatosylceramidase (GALC) leading to abnormalities of myelin formation in both the central and peripheral nervous system. It is often fatal.

Worldwide it is estimated to affect 1 in 100,000-200,000 births, although a higher incidence occurs in certain groups, eg some Israeli communities.[1][2] Males and females are equally affected.

Save time & improve your PDP on Patient.co.uk

  • Notes Add notes to any clinical page and create a reflective diary
  • Track Automatically track and log every page you have viewed
  • Print Print and export a summary to use in your appraisal
Click to find out more »

The mutation in Krabbe's disease is located to the human chromosome 14 and more than 40 mutations have been identified.[2] This mutation of the galactosylceramidase (GALC) gene leads to a GALC deficiency. Deficiency of this enzyme leads to an inability to break down lipids in the myelin, leading to reduced myelin production. However, it has been observed that this genotype alone may not account for the phenotype, suggesting that other genetic factors may also be important.[2][3]

There are two types of presentation:

  • Infantile form - the most common, with affected infants being normal at birth. 80% of cases develop features and are diagnosed in the first six months of life.
  • Late-onset form - later presentation including adulthood; rarer and milder, with slower progression.

Symptoms

These usually occur at 3-6 months:[4]

  • Irritability.
  • Crying.
  • Fever.
  • Feeding difficulties.
  • Limb stiffness.
  • Delayed achievement of developmental milestones.
  • Vomiting.
  • Blindness.
  • Seizures.

Signs

  • Cherry red spots.
  • Protruding ears.
  • Postural tremor of limbs.
  • Spasticity.
  • Hyperreflexia.
  • Clonus.
  • Pyramidal paresis of limb or limbs.
  • Extensor plantar responses.
  • Unsteadiness of gait.
  • Psychomotor retardation.
  • Dysphagia.
  • Deafness.

Adults commonly present with motor skill problems, paraesthesia, weakness and cognitive deficits.

  • Galactosylceramidase (GALC) enzyme activity - from blood or skin fibroblasts (activity reduced).
  • MRI - demyelination of white matter of the brain and, more rarely, the spinal cord.[5][6]
  • Lumbar puncture will show raised CSF protein.
  • Nerve conduction - can be normal; however, most have some abnormalities, eg delayed brainstem auditory evoked potentials and visual evoked potentials.
  • Histology - presence of PAS-positive material extracellularly and cerithin in microglial cells with characteristic 'globoid cells' in brain tissue.[2]
  • EEG.
  • Genetic studies.

This can be performed with chorionic villous sampling.[2]

  • There is no cure yet and thus management is mainly supportive, eg physiotherapy, anticonvulsants.
  • Allogeneic haematopoietic stem cell transplantation in early disease leads to reversal of CNS deterioration.[7][8]
  • Transplantation of umbilical cord blood from unrelated donors leads to neurological improvement in those who received this therapy before the development of symptoms.[9]

Parents and carers will need education and support. Parents will require genetic counselling before further pregnancies.

Poor in infantile forms with death usually before the age of 2 years.[4] However, some cases have been reported to live beyond the teens. In late-onset disease, cases progress slower and the spectrum and severity of the illness are very variable.

Further reading & references

  1. Krabbe disease, Genetics Home Reference, US National Library of Medicine
  2. Krabbe Disease, Online Mendelian Inheritance in Man (OMIM)
  3. Xu C, Sakai N, Taniike M, et al; Six novel mutations detected in the GALC gene in 17 Japanese patients with Krabbe disease, and new genotype-phenotype correlation. J Hum Genet. 2006;51(6):548-54. Epub 2006 Apr 11.
  4. Krabbe disease, PubMed Health, May 2011
  5. Given CA 2nd, Santos CC, Durden DD; Intracranial and spinal MR imaging findings associated with Krabbe's disease: case report. AJNR Am J Neuroradiol. 2001 Oct;22(9):1782-5.
  6. Provenzale JM, Peddi S, Kurtzberg J, et al; Correlation of neurodevelopmental features and MRI findings in infantile Krabbe's AJR Am J Roentgenol. 2009 Jan;192(1):59-65.
  7. Siddiqi ZA, Sanders DB, Massey JM; Peripheral neuropathy in Krabbe disease: effect of hematopoietic stem cell transplantation. Neurology. 2006 Jul 25;67(2):268-72.
  8. McGraw P, Liang L, Escolar M, et al; Krabbe disease treated with hematopoietic stem cell transplantation: serial assessment of anisotropy measurements--initial experience. Radiology. 2005 Jul;236(1):221-30.
  9. Escolar ML, Poe MD, Provenzale JM, et al; Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease. N Engl J Med. 2005 May 19;352(20):2069-81.
Original Author: Prof Cathy Jackson, Dr Gurvinder Rull Current Version: Peer Reviewer: Dr Colin Tidy
Last Checked: 19/08/2011 Document ID: 2365  Version: 22 © EMIS

Disclaimer: This article is for information only and should not be used for the diagnosis or treatment of medical conditions. EMIS has used all reasonable care in compiling the information but make no warranty as to its accuracy. Consult a doctor or other health care professional for diagnosis and treatment of medical conditions. For details see our conditions.

Advertisements